Which anti-anxiety medication is least likely to cause constipation?

Which Anti-Anxiety Medication Causes Least Constipation

For anti-anxiety medications, SSRIs (selective serotonin reuptake inhibitors) cause the least constipation compared to other commonly used options, with benzodiazepines being a reasonable alternative, though they carry their own constipation risk. Among SSRIs specifically, mirtazapine has the fewest gastrointestinal side effects overall, though it increases appetite 1.

Understanding the Constipation Risk Profile

The evidence clearly shows different classes of medications used for anxiety have vastly different constipation profiles:

Tricyclic Antidepressants (TCAs) - HIGHEST Risk

TCAs cause constipation through their anticholinergic effects (muscarinic receptor blockade) 2, 3. This is a well-established and common side effect that limits their use 2, 3. However, if TCAs must be used:

• Secondary amine TCAs (desipramine, nortriptyline) have lower anticholinergic effects and cause less constipation than tertiary amines like amitriptyline 3
• This makes them preferable when constipation is a concern

SSRIs - LOWEST Risk Among Antidepressants

SSRIs actually increase gastric and intestinal motility rather than decreasing it 3. The comprehensive meta-analysis by 1 examining gastrointestinal side effects across antidepressants found:

• Mirtazapine had the fewest gastrointestinal side effects overall, only associated with increased appetite
• Escitalopram and sertraline were associated with more GI effects, but notably NOT constipation
• SSRIs are more likely to cause diarrhea or nausea than constipation

SNRIs (Duloxetine) - MODERATE to HIGH Risk

Duloxetine specifically causes constipation as a limiting adverse effect 4. In an open-label trial, constipation was significant enough that 7 of 15 participants withdrew due to adverse effects, with constipation being notably problematic 4.

Benzodiazepines - MODERATE Risk

Benzodiazepines are significantly associated with constipation and laxative use 5. A 2025 study found:

• 66.1% of patients on benzodiazepines required laxatives versus 39.0% not on benzodiazepines
• Multivariate analysis showed benzodiazepines had an odds ratio of 3.059 for requiring laxatives 5
• The mean number of benzodiazepines prescribed was significantly higher in those requiring laxatives 5

Clinical Algorithm for Selection

When choosing an anti-anxiety medication with minimal constipation risk:

1. First-line choice: SSRIs (particularly mirtazapine if sedation is acceptable, or standard SSRIs like fluoxetine, citalopram, paroxetine)

   • These increase GI motility rather than decrease it 3
   • Mirtazapine has the best overall GI tolerability profile 1

2. Second-line: Benzodiazepines (if short-term use for acute anxiety)

   • Moderate constipation risk but less than TCAs 5
   • Should be used cautiously and not long-term

3. Avoid if constipation is a concern:

   • Tertiary amine TCAs (amitriptyline, imipramine, doxepin)
   • SNRIs like duloxetine 4

4. If TCA is necessary (for comorbid pain conditions):

   • Use secondary amines: desipramine or nortriptyline 3
   • Start low (10 mg) and titrate slowly
   • Implement prophylactic bowel regimen

Important Caveats

• Anxiety symptoms themselves can be associated with constipation 6, so treating the underlying anxiety may improve bowel function regardless of medication choice
• The guidelines consistently note that SSRIs have weak evidence for treating anxiety in IBS contexts 2, 3, but this doesn't negate their favorable constipation profile for primary anxiety disorders
• Patient-specific factors matter: females have higher constipation risk 6, and adequate hydration (>3000cc daily) reduces risk 6
• Multiple medications compound risk - anticholinergic burden from multiple sources increases constipation 6